When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HEPA - Hepion Pharma lead drug shows positive effect in renal fibrosis model
Hepion Pharmaceuticals Inc.
Nano cap Hepion Pharmaceuticals (NASDAQ:HEPA) announces encouraging results from a Japan-based lab study evaluating lead candidate CRV431 in a mouse model of renal fibrosis (scarring).
More news on: Hepion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,